Laura Sepp-Lorenzino, EVP, Chief Scientific Officer at Intellia Therapeutics, holds 81.89K shares in Intellia Therapeutics (Ticker: NTLA), holds ― shares in Taysha Gene Therapies (Ticker: TSHA).

See the Hottest Stocks Based on Insider Trading >

Laura Sepp-Lorenzino
Intellia Therapeutics (NTLA)
EVP, Chief Scientific Officer

Ranked #21,684 out of 98,624 Corporate Insiders

Profitable Transactions

3 out of 3 Profitable Transactions

Average Return

+30.30%

Average return per transaction

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

100.00%

NTLA

0.00%

TSHA

A breakdown of Laura Sepp-Lorenzino's holdings

See the Top Stocks by Insiders

Insider Roles

Intellia Therapeutics
(NTLA)

EVP, Chief Scientific Officer

Taysha Gene Therapies
(TSHA)

Director

Roles that Laura Sepp-Lorenzino holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Intellia Therapeutics
(NTLA)

Rating:Informative Sell

Date:Mar 03, 2022 - Mar 03, 2023

Return:+38.80%

The most profitable trade made by Laura Sepp-Lorenzino

See the Latest Stocks Traded by Insiders

Laura Sepp-Lorenzino's Trading History

NTLA

Intellia Therapeutics

Mar 05, 2024

EVP, Chief Scientific Officer

Uninformative Buy

―

$1.70M

TSHA

Taysha Gene Therapies

―

Director

―

List of latest transactions for each holding click on a transaction to see Laura Sepp-Lorenzino's performance on stock

See All Insider Trading from Today

Laura Sepp-Lorenzino insider profile FAQ

What is the percentage of profitable transactions made by Laura Sepp-Lorenzino?

The percentage of profitable transactions made by Laura Sepp-Lorenzino is 100%.

What is the average return per transaction made by Laura Sepp-Lorenzino?

The average return per transaction made by Laura Sepp-Lorenzino is 30.30%.

What stocks does Laura Sepp-Lorenzino hold?

Laura Sepp-Lorenzino holds: NTLA, TSHA stocks.

What was Laura Sepp-Lorenzino’s latest transaction?

Laura Sepp-Lorenzino latest transaction was an Uninformative Buy of ―.

What was Laura Sepp-Lorenzino's most profitable transaction?

Laura Sepp-Lorenzino’s most profitable transaction was an Informative Sell of NTLA stock on March 3, 2022. The return on the trade was 38.80%.

What is Laura Sepp-Lorenzino's role in Intellia Therapeutics?

Laura Sepp-Lorenzino's role in Intellia Therapeutics is EVP, Chief Scientific Officer.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Laura Sepp-Lorenzino Insider Profile

Laura Sepp-Lorenzino Intellia Therapeutics (NTLA)EVP, Chief Scientific Officer